Regeneron (REGN) Tops Q3 EPS by $6.15
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $612.50 +0.42%
EPS Growth %: -15.8%
Financial Fact:
Research and development: 543.05M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -15.8%
Financial Fact:
Research and development: 543.05M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q3 EPS of $15.37, $6.15 better than the analyst estimate of $9.22. Revenue for the quarter came in at $3.45 billion versus the consensus estimate of $2.76 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
- Sun Communities names Ileana McAlary as general counsel and EVP
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
